Pfizer, Ranbaxy Can't Pause Lipitor Pay-For-Delay Suit
A New Jersey judge has refused to halt multidistrict antitrust litigation challenging patent infringement settlements Pfizer Inc. reached over its cholesterol treatment Lipitor, ruling that waiting for the U.S. Supreme Court...To view the full article, register now.
Already a subscriber? Click here to view full article